Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Hormone Receptor Positive HER-2 Negative Breast Cancer × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Endometrial Neoplasms 3 Progesterone Resistance 2 Polycystic Ovary Syndrome 2 Endometrial Hyperplasia 2 Uterine Neoplasms 1 Obesity 1 Neoplasm Metastasis 1 Inflammatory Breast Neoplasms 1 Infertility 1 Hydatidiform Mole 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Gestational Trophoblastic Disease 1 Carcinoma, Ductal, Breast 1 Breast Diseases 1

Interventions

palbociclib 1 Letrozole 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02692755 2021-09-28

PALINA

Georgetown University

Phase 2/3 Completed

35 enrolled 12 charts

Hormone Receptor Positive HER-2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡